Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Neuronetics, Inc. (STIM) had Revenue of $41.78M for the most recently reported fiscal quarter, ending 2025-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-12-31

Income Statement Financials
Revenue	$41.78M
Net Income	$-7.16M
Cost of Goods Sold	$20.07M
Gross Profit	$21.70M
Operating Expenses	$46.82M
Operating Income	$-5.04M
Non-Operating Income/Expense	$-2.16M
Pre-Tax Income	$-7.21M
Normalized Pre-Tax Income	$-7.21M
Income after Taxes	$-7.21M
Income from Continuous Operations	$-7.21M
Consolidated Net Income/Loss	$-7.21M
Normalized Income after Taxes	$-7.21M
EBIT	$-5.04M
EBITDA	$-4.28M
Weighted-Average Shares Outstanding (Basic)	65.95M
Weighted-Average Shares Outstanding (Diluted)	65.95M
Earnings per Share (EPS) (Basic)	$-0.10
Earnings per Share (EPS) (Diluted)	$-0.10
Balance Sheet Financials
Current Assets	$61.55M
Property, Plant, and Equipment	$4.47M
Long-Term Assets	$80.00M
Total Assets	$141.55M
Current Liabilities	$30.52M
Long-Term Debt	$65.81M
Long-Term Liabilities	$84.79M
Total Liabilities	$115.31M
Common Equity	$26.24M
Tangible Shareholders Equity	$-15.53M
Shareholders Equity	$26.24M
Common Shares Outstanding	68.99M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-20.37M
Cash Flow from Investing Activities	$-0.80M
Cash Flow from Financial Activities	$35.85M
Beginning Cash	$19.46M
End Cash	$34.13M
Increase/Decrease in Cash	$14.68M
Stock-Based Compensation	$6.85M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.02
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.71
Debt to Equity Ratio	2.51
Gross Margin	51.95%
Operating Margin	-12.07%
EBIT Margin	-12.07%
EBITDA Margin	--
Pre-Tax Profit Margin	-17.25%
Profit Margin	-17.13%
Free Cash Flow	$-21.18M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.30
Inventory Turnover	4.64
Receiveable Turnover	2.47
Days Sales in Receivables	36.39
Return on Equity	-27.46%
Return on Tangible Equity	46.40%
Return on Assets	-5.09%
Return on Investments	-7.83%
Book Value Per Share	$0.38
Free Cash Flow per Share	$-0.32
Operating Cash Flow per Share	$-0.31

Data from Zacks Investment Research, Inc.